LabGenius, a London-based drug discovery company, has raised £35M in a Series B funding round led by M Ventures. The company uses machine learning…
Browsing: LabGenius
LabGenius, a company that uses machine learning for antibody discovery, has secured £35 million in funding to develop their proprietary platform and progress a…
LabGenius, a London-based drug discovery company, has closed a Series B financing round of over €40.1 million. The company uses machine learning and a…